Helieh S. Oz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helieh S. Oz has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Theresa S. Chen
Department of Pharmacology and Toxicology, University of Louisville Medical School, Louisville, Kentucky
6 shared publicationsJeffrey L. Ebersole
5 shared publicationsJian Zhong
4 shared publicationsWillem J. de Villiers
4 shared publicationsWillem J. De Villiers
3 shared publicationsCraig J. McClain
VAMC, Louisville KY, USA
2 shared publications
Latest Publications
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1644 Green Tea Polyphenols and Sulfasalazine Have Parallel Anti-Inflammatory Properties in Colitis Models
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1644 Green Tea Polyphenols and Sulfasalazine Have Parallel Anti-Inflammatory Properties in Colitis Models
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
51 Novel Action of Pegylated Arginine Deiminase to Protect Against Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
51 Novel Action of Pegylated Arginine Deiminase to Protect Against Colitis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
“Human Babesiosis” an Emerging Transfusion Dilemma: Acridine Orange as a Feasible Diagnostic Technology
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
“Human Babesiosis” an Emerging Transfusion Dilemma: Acridine Orange as a Feasible Diagnostic Technology
- Open Access
- 1 January 2011
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 754857
Animal Models for Periodontal Disease
Animal models and cell cultures have contributed new knowledge in biological sciences, including periodontology. Although cultured cells can be used to study physiological processes that occur during the pathogenesis of periodontitis, the complex host response fundamentally responsible for this disease cannot be reproduced in vitro. Among the animal kingdom, rodents, rabbits, pigs, dogs, and nonhuman primates have been used to model human periodontitis, each with advantages and disadvantages. Periodontitis commonly has been induced by placing a bacterial plaque retentive ligature in the gingival sulcus around the molar teeth. In addition, alveolar bone loss has been induced by inoculation or injection of human oral bacteria (e.g., Porphyromonas gingivalis) in different animal models. While animal models have provided a wide range of important data, it is sometimes difficult to determine whether the findings are applicable to humans. In addition, variability in host responses to bacterial infection among individuals contributes significantly to the expression of periodontal diseases. A practical and highly reproducible model that truly mimics the natural pathogenesis of human periodontal disease has yet to be developed.
- 1 January 2011
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 754857
Open AccessAnimal Models for Periodontal Disease
Animal models and cell cultures have contributed new knowledge in biological sciences, including periodontology. Although cultured cells can be used to study physiological processes that occur during the pathogenesis of periodontitis, the complex host response fundamentally responsible for this disease cannot be reproduced in vitro. Among the animal kingdom, rodents, rabbits, pigs, dogs, and nonhuman primates have been used to model human periodontitis, each with advantages and disadvantages. Periodontitis commonly has been induced by placing a bacterial plaque retentive ligature in the gingival sulcus around the molar teeth. In addition, alveolar bone loss has been induced by inoculation or injection of human oral bacteria (e.g., Porphyromonas gingivalis) in different animal models. While animal models have provided a wide range of important data, it is sometimes difficult to determine whether the findings are applicable to humans. In addition, variability in host responses to bacterial infection among individuals contributes significantly to the expression of periodontal diseases. A practical and highly reproducible model that truly mimics the natural pathogenesis of human periodontal disease has yet to be developed.
- 15 August 2010
- Published by Springer Nature in Inflammation Research
- Vol. 60 (1) , 93-97
The macrophage pattern recognition scavenger receptors SR-A and CD36 protect against microbial induced pregnancy loss
Microbial products can act via stress-induced signaling cascades to link dysregulated endogenous microbiota to immune activation (e.g., macrophages) and pregnancy loss. Our previous studies demonstrated that mice deficient in the macrophage pattern recognition scavenger receptors, SR-A and CD36, are more susceptible to inflammatory complications including gut leakiness and experimental colitis. We hypothesized that bacterial penetration of the maternal mucosal surfaces and replication in embryonic fluids compromise the fetal status and can result in miscarriage.
- 15 August 2010
- Published by Springer Nature in Inflammation Research
- Vol. 60 (1) , 93-97
The macrophage pattern recognition scavenger receptors SR-A and CD36 protect against microbial induced pregnancy loss
Microbial products can act via stress-induced signaling cascades to link dysregulated endogenous microbiota to immune activation (e.g., macrophages) and pregnancy loss. Our previous studies demonstrated that mice deficient in the macrophage pattern recognition scavenger receptors, SR-A and CD36, are more susceptible to inflammatory complications including gut leakiness and experimental colitis. We hypothesized that bacterial penetration of the maternal mucosal surfaces and replication in embryonic fluids compromise the fetal status and can result in miscarriage.
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S2082 Green Tea Polyphenols Mediate Apoptosis in Intestinal Epithelial Cells
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S2082 Green Tea Polyphenols Mediate Apoptosis in Intestinal Epithelial Cells
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S1751 The Macrophage Pattern Recognition Scavenger Receptors SR-A and CD36 Protect Against Microbial Induced Pregnancy Loss
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S1751 The Macrophage Pattern Recognition Scavenger Receptors SR-A and CD36 Protect Against Microbial Induced Pregnancy Loss
- 14 January 2010
- Published by Wiley in Journal of Periodontal Research
- Vol. 45 (1) , 94-99
A novel murine model for chronic inflammatory alveolar bone loss
Oz HS, Ebersole JL. A novel murine model for chronic inflammatory alveolar bone loss. J Periodont Res 2009; doi: 10.1111/j.1600‐0765.2009.01207.x. © 2009 John Wiley & Sons A/S Background and Objective: Chronic inflammatory bowel disease (IBD) demonstrates some similarities to the dysregulated chronic immunoinflammatory lesion of periodontitis. Trinitrobenzene sulphonic acid (TNBS) and dextran sodium sulphate (DSS) administered to rodents have been shown to elicit inflammatory responses that undermine the integrity of the gut epithelium in a similar manner to IBD in humans. The objective of this study was to evaluate the ability of these chemicals to elicit periodontal inflammation as a novel model for alveolar bone loss. Material and Methods: Mice were treated by oral application of TNBS twice a week, or with DSS in the diet over a period of 18 weeks. Alveolar bone loss was assessed on the defleshed skull using morphometric measures for area of bone resorption. Results: The TNBS‐treated animals tolerated oral administration with no clinical symptoms and gained weight at a similar rate to normal control animals. In contrast, DSS exerted a systemic response, including shortening of colonic tissue and liver enzyme changes. Both TNBS and DSS caused a localized action on periodontal tissues, with alveolar bone loss observed in both maxilla and mandibles, with progression in a time‐dependent manner. Bone loss was detected as early as week 7, with more severe periodontitis increasing over the 18 weeks (p < 0.001). Young (7‐month‐old) and old (12‐month‐old) mice with severe combined immunodefiency were treated with TNBS for a period of 7 weeks and did not develop significant bone loss. Conclusion: These data show that oral administration of TNBS or DSS provokes alveolar bone loss in concert with the autochthonous oral microbiota.
- 14 January 2010
- Published by Wiley in Journal of Periodontal Research
- Vol. 45 (1) , 94-99
A novel murine model for chronic inflammatory alveolar bone loss
Oz HS, Ebersole JL. A novel murine model for chronic inflammatory alveolar bone loss. J Periodont Res 2009; doi: 10.1111/j.1600‐0765.2009.01207.x. © 2009 John Wiley & Sons A/S Background and Objective: Chronic inflammatory bowel disease (IBD) demonstrates some similarities to the dysregulated chronic immunoinflammatory lesion of periodontitis. Trinitrobenzene sulphonic acid (TNBS) and dextran sodium sulphate (DSS) administered to rodents have been shown to elicit inflammatory responses that undermine the integrity of the gut epithelium in a similar manner to IBD in humans. The objective of this study was to evaluate the ability of these chemicals to elicit periodontal inflammation as a novel model for alveolar bone loss. Material and Methods: Mice were treated by oral application of TNBS twice a week, or with DSS in the diet over a period of 18 weeks. Alveolar bone loss was assessed on the defleshed skull using morphometric measures for area of bone resorption. Results: The TNBS‐treated animals tolerated oral administration with no clinical symptoms and gained weight at a similar rate to normal control animals. In contrast, DSS exerted a systemic response, including shortening of colonic tissue and liver enzyme changes. Both TNBS and DSS caused a localized action on periodontal tissues, with alveolar bone loss observed in both maxilla and mandibles, with progression in a time‐dependent manner. Bone loss was detected as early as week 7, with more severe periodontitis increasing over the 18 weeks (p < 0.001). Young (7‐month‐old) and old (12‐month‐old) mice with severe combined immunodefiency were treated with TNBS for a period of 7 weeks and did not develop significant bone loss. Conclusion: These data show that oral administration of TNBS or DSS provokes alveolar bone loss in concert with the autochthonous oral microbiota.
- 10 November 2009
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (8) , 2194-2202
A Model for Chronic Mucosal Inflammation in IBD and Periodontitis
Chronic inflammation of mucosal surfaces is an aberrant immune response to luminal bacteria and generates an array of oxygen radicals leading to tissue destruction and loss of function, as noted in IBD and periodontitis. We hypothesized that mucosal injury after “oral delivery” of dextran sulfate sodium (DSS) or TNBS for an extended period of 18 weeks is reflected by chronic inflammatory responses in a time-dependent fashion. Dextran sulfate sodium was administered in the diet biweekly; TNBS or sham controls was administered orally twice a week. Additional groups received TNBS or sham injections into gingival tissue. Animals tolerated oral applications with no severe clinical symptoms. The DSS-group developed diarrhea during the period of administration, and returned to normal during DSS abstinence. The TNBS-group developed no systemic clinical symptoms. Splenic length and weight increased in the DSS-group in a time-dependent fashion (P < 0.01) and remained normal in the TNBS-group. Colons from the DSS-group were significantly shortened (P < 0.001) and colonic weight increased compared with controls or the TNBS-group (P < 0.05). The DSS-group developed extensive dilation of the stomach wall, ileum, and megacolon, with abdominal fat deposits. In addition, the DSS-group showed dysregulated hepatic concentrations of antioxidants (i.e. cysteine, GSH, SAMe) in a time-dependent manner that correlated with a significance increase in alveolar bone resorption. Localized TNBS-mucosal delivery caused severe inflammation, granuloma formation, and rapid bone resorption. This model of mucosal stimulation eliciting chronic inflammatory responses in the gut and oral cavity mimics aspects of IBD and periodontal disease progression in patients.
- 10 November 2009
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (8) , 2194-2202
A Model for Chronic Mucosal Inflammation in IBD and Periodontitis
Chronic inflammation of mucosal surfaces is an aberrant immune response to luminal bacteria and generates an array of oxygen radicals leading to tissue destruction and loss of function, as noted in IBD and periodontitis. We hypothesized that mucosal injury after “oral delivery” of dextran sulfate sodium (DSS) or TNBS for an extended period of 18 weeks is reflected by chronic inflammatory responses in a time-dependent fashion. Dextran sulfate sodium was administered in the diet biweekly; TNBS or sham controls was administered orally twice a week. Additional groups received TNBS or sham injections into gingival tissue. Animals tolerated oral applications with no severe clinical symptoms. The DSS-group developed diarrhea during the period of administration, and returned to normal during DSS abstinence. The TNBS-group developed no systemic clinical symptoms. Splenic length and weight increased in the DSS-group in a time-dependent fashion (P < 0.01) and remained normal in the TNBS-group. Colons from the DSS-group were significantly shortened (P < 0.001) and colonic weight increased compared with controls or the TNBS-group (P < 0.05). The DSS-group developed extensive dilation of the stomach wall, ileum, and megacolon, with abdominal fat deposits. In addition, the DSS-group showed dysregulated hepatic concentrations of antioxidants (i.e. cysteine, GSH, SAMe) in a time-dependent manner that correlated with a significance increase in alveolar bone resorption. Localized TNBS-mucosal delivery caused severe inflammation, granuloma formation, and rapid bone resorption. This model of mucosal stimulation eliciting chronic inflammatory responses in the gut and oral cavity mimics aspects of IBD and periodontal disease progression in patients.
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
W1673 SR-A and CD36 Scavenger Receptors Protect Against the Progression of Colitis in Mice
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
W1673 SR-A and CD36 Scavenger Receptors Protect Against the Progression of Colitis in Mice